NL-OMON37346已完成不适用
Pharmacokinetic Interaction between Antiretroviral and Cytotoxic therapy in HIV-infected patients - a pilot study - Phineac-study
Onze Lieve Vrouwe Gasthuis0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Biopsy proven lymphoma
- •Treated with cyclophosphamide, doxorubicin, vinblastine and/or vincristine
- •proven HIV positive on HAART
排除标准
- •Seriously compromised peripheral venous vasculature complicating venous blood sampling
- •No written informed consent obtained
研究者
相似试验
尚未招募
4 期
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and PostpartumTuberculosisPACTR202012605595028ational Institute of Allergy and Infectious Diseases30
招募中
不适用
The interaction of Antiretroviral Drugs with the MicrobiomeCirculatory SystemHIV/AIDSNutritional, Metabolic, EndocrinePACTR202108587192356WS300
终止
不适用
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and PostpartumTuberculosisHIV InfectionsHIVNCT04518228National Institute of Allergy and Infectious Diseases (NIAID)205
已完成
1 期
Interaction With HIV Antiretroviral AgentsHIV-DDINCT02556268Bayer40
进行中（未招募）
不适用
Study about pharmacokinetic interactions between Telaprevir and Atazanavir in co-infected patients with HIV and hepatitis C wiht chronic liver disease due to hepatitis C.EUCTR2012-002515-25-ESuis López Cortes - FISEVI12